NCT05504031View on ClinicalTrials.gov

Hybrid Revascularization Versus Coronary Artery Bypass Grafting

NANot yet recruitingINTERVENTIONAL
Enrollment

1,048

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2040

Conditions
Coronary Artery Disease
Interventions
PROCEDURE

Hybrid coronary revascularization

Coronary revascularization is conducted as a combined MIDCAB (LIMA-LAD grafting through a minimally invasive anterior left thoracotomy) and PCI (of all non-LAD stenoses)

PROCEDURE

Conventional revascularization

Conventional revascularization with CABG of all significant stenoses through a sternotomy

All Listed Sponsors
collaborator

Copenhagen Trial Unit, Center for Clinical Intervention Research

OTHER

collaborator

UMC Utrecht

OTHER

collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

lead

Rigshospitalet, Denmark

OTHER